Overview
Vektor Medical introduces VMap, an AI-driven arrhythmia analysis tool designed to transform cardiac care. With a focus on improving ablation outcomes, workflow optimization, and procedural efficiency, VMap addresses the global health crisis posed by cardiac arrhythmias.
Features
- Accurate Mapping:
- AI-based analysis from standard ECG.
- Precise mapping of Atrial Fibrillation and six other arrhythmias.
- Optimized for seamless integration into current procedural workflows.
- Provides rich insights from non-invasive, ECG mapping.
- FDA-Indicated for 7 Arrhythmias & 2 Pacing Types:
- Cleared by the U.S FDA for atrial and ventricular tachycardia, fibrillation, pacing, premature complexes (PACs and PVCs), and orthodromic atrioventricular reentrant tachycardia.
- Clinical Studies: The vMap Study demonstrates impressive regional accuracy for various arrhythmias, with blinded, multi-center, and independently adjudicated methodologies. Another study reveals vMap’s association with decreased procedural time, fluoroscopy use, and cost, emphasizing its practical benefits.
Use Cases
- Cardiac Ablation Optimization: vMap enhances cardiac ablation outcomes, optimizing workflows, and increasing procedural efficiency, crucial in addressing the global prevalence of serious arrhythmias.
- Procedure Throughput Enhancement: A retrospective study indicates a 20% lift in procedure throughput, accompanied by a significant reduction in procedural duration and fluoroscopy time.
- Radio-Ablation Planning: In a dual-site study, vMap aids in optimizing stereotactic ablative radiotherapy workflow for refractory ventricular tachycardia, showcasing its versatility beyond traditional procedures.
VMap is a groundbreaking AI tool poised to redefine arrhythmia care. With FDA clearance for diverse arrhythmias, its accuracy in mapping, and the positive outcomes demonstrated in clinical studies, VMap promises to elevate procedural efficiency, reduce costs, and enhance patient outcomes. By combining advanced algorithms with non-invasive mapping, VMap showcases an intuitive, accurate, and physician-friendly solution that aligns seamlessly with current practices.
In the hands of physicians, VMap stands as a testament to innovation, offering a transformative approach to addressing the complexities of arrhythmia management. Covered by multiple patents, its potential to revolutionize cardiac care is evident, providing a beacon of hope for both clinicians and patients in the ever-evolving landscape of cardiovascular health.
Request More Information and Experience the Power of VMap:
https://vektormedical.com/
Note: VMap® is covered by multiple US Patents, with additional patents pending.